262 related articles for article (PubMed ID: 30260234)
1. Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects.
Allahverdiyev AM; Parlar E; Dinparvar S; Bagirova M; Abamor EŞ
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S755-S762. PubMed ID: 30260234
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches.
Malliappan SP; Kandasamy P; Chidambaram S; Venkatasubbu D; Perumal SK; Sugumaran A
Anticancer Agents Med Chem; 2020; 20(11):1300-1310. PubMed ID: 31642415
[TBL] [Abstract][Full Text] [Related]
4. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
Kumar L; Baldi A; Verma S; Utreja P
Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
[TBL] [Abstract][Full Text] [Related]
5. Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer.
Wang B; Rosano JM; Cheheltani R; Achary MP; Kiani MF
Expert Opin Drug Deliv; 2010 Oct; 7(10):1159-73. PubMed ID: 20738211
[TBL] [Abstract][Full Text] [Related]
6. A Review on Targeting Nanoparticles for Breast Cancer.
Alqaraghuli HGJ; Kashanian S; Rafipour R
Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
[TBL] [Abstract][Full Text] [Related]
7. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
[TBL] [Abstract][Full Text] [Related]
8. Surface engineered nanocarriers for the management of breast cancer.
Nitheesh Y; Pradhan R; Hejmady S; Taliyan R; Singhvi G; Alexander A; Kesharwani P; Dubey SK
Mater Sci Eng C Mater Biol Appl; 2021 Nov; 130():112441. PubMed ID: 34702526
[TBL] [Abstract][Full Text] [Related]
9. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
10. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
[TBL] [Abstract][Full Text] [Related]
11. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer.
Behl A; Chhillar AK
Recent Pat Anticancer Drug Discov; 2023; 18(3):325-342. PubMed ID: 35702804
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology: An Emerging Therapeutic Option for Breast Cancer.
Hussain Z; Khan JA; Murtaza S
Crit Rev Eukaryot Gene Expr; 2018; 28(2):163-175. PubMed ID: 30055543
[TBL] [Abstract][Full Text] [Related]
13. Exosome vesicle as a nano-therapeutic carrier for breast cancer.
Mughees M; Kumar K; Wajid S
J Drug Target; 2021 Feb; 29(2):121-130. PubMed ID: 32787592
[TBL] [Abstract][Full Text] [Related]
14. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
[TBL] [Abstract][Full Text] [Related]
16. Colloidal Nanocarriers as Versatile Targeted Delivery Systems for Cervical Cancer.
Sugumaran A; Mathialagan V
Curr Pharm Des; 2020; 26(40):5174-5187. PubMed ID: 32586249
[TBL] [Abstract][Full Text] [Related]
17. Application of chitosan modified nanocarriers in breast cancer.
Dubey SK; Bhatt T; Agrawal M; Saha RN; Saraf S; Saraf S; Alexander A
Int J Biol Macromol; 2022 Jan; 194():521-538. PubMed ID: 34822820
[TBL] [Abstract][Full Text] [Related]
18. Nanocarrier based approaches for targeting breast cancer stem cells.
Pindiprolu SKSS; Krishnamurthy PT; Chintamaneni PK; Karri VVSR
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):885-898. PubMed ID: 28826237
[TBL] [Abstract][Full Text] [Related]
19. Advances in the use of nanocarriers for cancer diagnosis and treatment.
Vieira DB; Gamarra LF
Einstein (Sao Paulo); 2016; 14(1):99-103. PubMed ID: 27074238
[TBL] [Abstract][Full Text] [Related]
20. Exosomes as drug carriers for clinical application.
Di C; Zhang Q; Wang Y; Wang F; Chen Y; Gan L; Zhou R; Sun C; Li H; Zhang X; Yang H; Zhang H
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S564-S570. PubMed ID: 30431368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
